2020
DOI: 10.1371/journal.pone.0236676
|View full text |Cite
|
Sign up to set email alerts
|

Accuracy of consumer-based activity trackers as measuring tool and coaching device in patients with COPD and healthy controls

Abstract: Background Consumer-based activity trackers are used to measure and improve physical activity. However, the accuracy of these devices as clinical endpoint or coaching tool is unclear. We investigated the use of two activity trackers as measuring and coaching tool in patients with Chronic Obstructive Pulmonary Disease (COPD) and healthy age-matched controls. Methods Daily steps were measured by two consumer-based activity trackers (Fitbit Zip, worn at the hip and Fitbit Alta, worn at the wrist) and a validated … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
22
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 15 publications
(25 citation statements)
references
References 26 publications
2
22
0
1
Order By: Relevance
“…In total, 23 different physical disabilities and/or chronic diseases were included in the studies. Most studies included people with stroke ( n = 27) [ 40 66 ], chronic obstructive pulmonary disease ( n = 11) [ 67 77 ] and multiple sclerosis ( n = 10) [ 78 87 ]. Six studies included a mixed population of people with different physical disabilities and/or chronic diseases [ 23 , 75 , 77 , 88 90 ].…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…In total, 23 different physical disabilities and/or chronic diseases were included in the studies. Most studies included people with stroke ( n = 27) [ 40 66 ], chronic obstructive pulmonary disease ( n = 11) [ 67 77 ] and multiple sclerosis ( n = 10) [ 78 87 ]. Six studies included a mixed population of people with different physical disabilities and/or chronic diseases [ 23 , 75 , 77 , 88 90 ].…”
Section: Resultsmentioning
confidence: 99%
“…Sample sizes ranged from 4 to 176, with a median of 28. The majority of studies were performed in Northern America (USA, n = 28 [ 51 , 64 , 69 , 70 , 72 , 74 , 76 , 83 85 , 91 – 107 ]; Canada, n = 10 [ 40 , 47 , 50 , 52 , 53 , 89 , 108 – 111 ]) and Western Europe (UK, n = 11 [ 78 , 80 , 82 , 86 , 112 118 ]; France, n = 8 [ 42 – 45 , 55 , 119 ]; the Netherlands, n = 6 [ 48 , 75 , 77 , 120 122 ]; Germany, n = 4 [ 68 , 87 , 123 , 124 ]; Switzerland, n = 4 [ 66 , 81 , 125 , 126 ]; Denmark, n = 3 [ 127 – 129 ]; Belgium, n = 2 [ 67 , 88 ]; Italy, n = 2 [ 56 , 130 ]; Sweden, n = 2 [ 71 , 79 ]; Ireland, n = 1 [ 131 ]; Portugal, n = 1 [ 132 ]). Only 14 studies were performed in other countries (Brazil, n = 6 [ 46 , 49 , 57 , 62 , 63 , 133 ]; Japan, n = 4 [ 59 , 73 , 134 , 135 ]; Australia, n = 3 [ …”
Section: Resultsmentioning
confidence: 99%
“…Several studies have noted that only approximately 50% of the time will a Fitbit device provide accurate step measurement in controlled settings compared with research-grade devices 55. A recent study of consumer-grade activity tracker accuracy in people with COPD showed that the Fitbit Zip, worn at the hip, had a statistically significant underestimation of daily step count, and the Fitbit Alta, worn at the wrist, had a nonsignificant overestimation of daily step count 56. Clinicians may consider checking the accuracy of individual patients' personal devices, for instance, in comparison to actual steps taken during a session, to verify physical activity measures, especially for people with COPD, who have slower gait speeds.…”
Section: Discussionmentioning
confidence: 99%
“…Patients were instructed to wear a wrist- or waist-worn activity tracker (Fitbit, San Francisco, CA, USA) on a daily basis during waking hours for 12 months. This step counter is valid to identify day-by-day changes in patients with COPD [ 10 ]. Data on daily step count were collected through the coaching smartphone application (m-PAC, AppsOnly).…”
Section: Methodsmentioning
confidence: 99%